Top news of the week: 05.10.2023.
Biotech IPOs see gradual resurgence in Q3 2023, investor caution persists
Biotech IPOs see gradual resurgence in Q3 2023, investor caution persists
Lexeo’s $100 Million IPO: Jab in the Arm for Biotech?
October 3, 2023 It's been nothing but crickets in the biotech initial public offering (IPO) space this year, but investors who are hungry for a new pharma
Blockbuster Listings in Sep. Spark New Life into IPO ETFs
After hike-induced hibernation, IPO awakening signs emerge but where to get maximum IPO exposure?
VP2 residue N142 of coxsackievirus A10 is critical for the interaction with KREMEN1 receptor and neutralizing antibodies and the pathogenicity in mice
Author summary Coxsackievirus A10 (CVA10) is an emerging pathogen that causes hand, foot, and mouth disease. No approved vaccines or antiviral treatments for CVA10 infection are yet ...
Israel’s Fate Hangs in the Balance – Yom Kippur 5784
From the blog of David Lerner at The Times of Israel
Indian scientists welcome Nobel Prize for medicine, say mRNA vaccines can be developed for TB, dengue, other diseases
Dr Vinod Paul, member, the National Institution for Transforming India (NITI Aayog),said the mRNA pathway for vaccines has opened new doors.
Vaccines Grown in Lettuce? Rep. Massie Asks House to Bar FDA, USDA From Funding Transgenic Edible Vaccines
All Global Research articles can be read in 51 languages by activating the Translate Website button below the author’s name. To receive Global Research’s Daily Newsletter (selected ...
Healthy changes are happening in the primary market quietly
India Inc raised ₹17,500-cr in Q2, 65% of 2023 total. 24 companies from diverse sectors tapped capital markets. Funds raised ranged from ₹2,800-cr to ₹71-cr. 65-70% of funds were fresh ...